Diet Supplementation with Fish-Derived Extracts Suppresses Diabetes and Modulates Intestinal Microbiome in a Murine Model of Diet-Induced Obesity
Authors:
- Konstantinos AxarlisKAKonstantinos Axarlis
- Maria G. DaskalakiMaria G. Daskalaki
- Sofia MichailidouSMSofia Michailidou
- Nikolais AndroulakiNANikolais Androulaki
- Antiopi TsourekiATAntiopi Tsoureki
- Evangelia MouchtaropoulouEMEvangelia Mouchtaropoulou
- Ourania KolliniatiOKOurania Kolliniati
- Ioanna LapiILIoanna Lapi
- Eirini DermitzakiEDEirini Dermitzaki
- Maria VenihakiMaria Venihaki
- Katerina KousoulakiKKKaterina Kousoulaki
- Anagnostis ArgiriouAnagnostis Argiriou
Open Access
- 11 May 2021
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 19 (5) , 268
Abstract
Metabolic syndrome-related diseases affect millions of people worldwide. It is well established that changes in nutritional habits and lifestyle can improve or prevent metabolic-related pathologies such as type-2 diabetes and obesity. Previous reports have shown that nutritional supplements have the capacity to limit glucose intolerance and suppress diabetes development. In this study, we investigated the effect of dietary supplementation with fish-derived extracts on obesity and type 2 diabetes and their impact on gut microbial composition. We showed that nutritional supplements containing Fish Complex (FC), Fish Complex combined with Cod Powder (FC + CP), or Cod Powder combined with Collagen (CP + C) improved glucose intolerance, independent of abdominal fat accumulation, in a mouse model of diet-induced obesity and type 2 diabetes. In addition, collagen-containing supplements distinctly modulate the gut microbiome in high-fat induced obesity in mice. Our results suggest that fish-derived supplements suppress diet-induced type 2 diabetes, which may be partly mediated through changes in the gut microbiome. Thus, fish-derived supplements and particularly the ones containing fish collagen have potential beneficial properties as dietary supplements in managing type 2 diabetes and metabolic syndrome via modulation of the gut microbiome.Keywords
Funding Information
- Horizon 2020 Framework Programme (790956)
- co-financed by the European Union and Greek national funds in the framework of the National Roadmap for Research Infrastructures- CMBR (MIS 5002670)
This publication has 49 references indexed in Scilit:
- Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studiesNucleic Acids Research, 2012
- Linking Long-Term Dietary Patterns with Gut Microbial EnterotypesScience, 2011
- Complete genome sequence of Odoribacter splanchnicus type strain (1651/6T)Standards in Genomic Sciences, 2011
- Impact of Dietary Polyphenols on Carbohydrate MetabolismInternational Journal of Molecular Sciences, 2010
- The gut microbiota shapes intestinal immune responses during health and diseaseNature Reviews Immunology, 2009
- Evolution of Mammals and Their Gut MicrobesScience, 2008
- Bacteroides: the Good, the Bad, and the Nitty-GrittyClinical Microbiology Reviews, 2007
- Fast Food, Central Nervous System Insulin Resistance, and ObesityArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- ObesityThe Lancet, 2005
- Fat in all the wrong placesNature, 2002